Molly Dir - Aptinyx VP HR

APTXDelisted Stock  USD 0.07  0.01  16.67%   

Insider

Molly Dir is VP HR of Aptinyx
Phone847 871 0377
Webhttps://www.aptinyx.com

Aptinyx Management Efficiency

The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.
Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

David HanleyNuvation Bio
54
Jason DavisVirax Biolabs Group
52
MD DrScAllarity Therapeutics
81
MBA MDSpero Therapeutics
43
Ben MDNeurobo Pharmaceuticals
68
Dr IVAssembly Biosciences
52
Annie RasmussenAllarity Therapeutics
67
Satyavrat CFASpero Therapeutics
51
Professor MDAllarity Therapeutics
67
Daniel WelchNuvation Bio
63
Timothy MooreInstil Bio
63
MHROD SHRMSCPAssembly Biosciences
N/A
TsungShann JiangABVC Biopharma
70
Rowena AlbannaAditxt Inc
58
Claus PedersenAllarity Therapeutics
52
Karl MDAchilles Therapeutics PLC
57
Ian CritchleySpero Therapeutics
N/A
DPHIL DPhilCytomX Therapeutics
57
Cameron ShawVirax Biolabs Group
37
W VernonNuvation Bio
65
Lawrence CPAAdial Pharmaceuticals
68
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. Aptinyx (APTX) is traded on NASDAQ Exchange in USA and employs 12 people.

Management Performance

Aptinyx Leadership Team

Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathryn King, VP Operations
Norbert Riedel, President CEO, Director
Patrick Flavin, Sr Relations
Molly Dir, VP HR
Ashish Khanna, Chief Business Officer
Harald MD, VP Affairs
Tim Noffke, VP Staff
MD BCh, Pres CEO

Aptinyx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Aptinyx Stock

If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance